A randomized, multicenter phase III trial of bevacizumab plus capecitabine as maintenance treatment after initial treatment with bevacizumab plus XELOX in previously untreated metastatic colorectal cancer


Yalcin S., Uslu R., Dane F. , Yilmaz U., Zengin N., Buyukunal E., ...Daha Fazla

JOURNAL OF CLINICAL ONCOLOGY, cilt.29, sa.4, 2011 (SCI İndekslerine Giren Dergi) identifier